At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DNA Ginkgo Bioworks Holdings Inc.
Post-Market Trading 05-01 19:36:36 EDT
0.8421
-0.0490
-5.50%
盘后0.8577
+0.0156+1.85%
19:34 EDT
High0.9192
Low0.7907
Vol86.18M
Open0.8846
D1 Closing0.8911
Amplitude14.42%
Mkt Cap1.71B
Tradable Cap1.07B
Total Shares2.03B
T/O71.89M
T/O Rate6.80%
Tradable Shares1.27B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Applied DNA Sciences Unveils New Investor Engagement Material
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.